✦ LIBER ✦

GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease

✍ Scribed by Steven Jacobsen; Thomas Comery; Anthony Kreft; Scott Mayer; Margaret Zaleska; David Riddell; Jonathan Bard; Cathleen Gonzales; Glen Frick; S. Raje; S. Forlow; C. Balliet; M. Burczynski; Hong Wan; Boyd Harrison; Peter Reinhart; Menelas Pangalos; Robert Martone

Book ID: 118465479
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 41 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.05.472

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P2-302: GSI-953 is a potent APP-selectiv

P2-302: GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease

✍ Jacobsen, Steven; Comery, Thomas; Aschmies, Suzan; Zhou, Hua; Jin, Mei; Atchison 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Begacestat (GSI-953): A Novel, Selective

Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein -Secretase for the Treatment of Alzheimer's Disease

✍ Martone, R. L.; Zhou, H.; Atchison, K.; Comery, T.; Xu, J. Z.; Huang, X.; Gong, 📂 Article 📅 2009 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 400 KB

Discovery of SCH 900229, a Potent Presen

Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease

✍ Wu, Wen-Lian; Domalski, Martin; Burnett, Duane A.; Josien, Hubert; Bara, Thomas; 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 315 KB

P4-366: GSI-953, a potent and selective

P4-366: GSI-953, a potent and selective gamma-secretase inhibitor: Modulation of beta-amyloid peptides and plasma and cerebrospinal fluid pharmacokinetic/pharmacodynamic relationships in humans

✍ Frick, Glen; Raje, Sangeeta; Wan, Hong; Forlow, Stephen B.; Balliet, Carrie; Pas 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

APP-selective gamma secretase inhibitor

APP-selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease

✍ Schroeter, Sally; Brigham, Elizabeth; Motter, Ruth; Nishioka, Chris; Guido, Terr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

N-heteroaryl-piperidinyl-4-amines as sel

N-heteroaryl-piperidinyl-4-amines as selective GAMMA secretase modulators for the potential treatment of Alzheimer's disease

✍ Thomas Luebbers; Anja Limberg; Synese Jolidon; Erwin Goetschi; Helmut Jacobsen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB